(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --617.39M | 38.44%1.03B | 38.38%736.69M | 15.40%742.75M | --532.35M | 9.37%643.64M | --588.5M |
Operating income | 617.39M | 38.44%1.03B | 38.38%736.69M | 15.40%742.75M | 532.35M | 9.37%643.64M | 588.5M |
Cost of sales | ---292.46M | -62.91%-450.9M | -62.49%-310.31M | -35.41%-276.78M | ---190.97M | 2.78%-204.4M | ---210.25M |
Operating expenses | -292.46M | -62.91%-450.9M | -62.49%-310.31M | -35.41%-276.78M | -190.97M | 2.78%-204.4M | -210.25M |
Gross profit | 324.93M | 23.90%577.35M | 24.90%426.38M | 6.08%465.97M | 341.38M | 16.13%439.24M | 378.25M |
Selling expenses | ---108.88M | -38.01%-191.8M | -39.57%-132.04M | -54.64%-138.98M | ---94.61M | -30.22%-89.87M | ---69.01M |
Administrative expenses | ---290.24M | -86.00%-480.47M | -65.00%-310.54M | 1.83%-258.31M | ---188.21M | 9.26%-263.14M | ---289.99M |
Research and development expenses | ---147.47M | -27.45%-268.17M | -23.07%-188.58M | -20.76%-210.4M | ---153.22M | -40.45%-174.24M | ---124.05M |
Impairment and provision | ---3.39M | -136.01%-1.76M | -795.09%-3.46M | -654.55%-747K | ---387K | -104.01%-99K | --2.47M |
-Other impairment is provision | ---3.39M | -136.01%-1.76M | -795.09%-3.46M | -654.55%-747K | ---387K | -104.01%-99K | --2.47M |
Special items of operating profit | --87.11M | 811.32%388.31M | 256.88%80.87M | 89.55%42.61M | --22.66M | -72.83%22.48M | --82.73M |
Operating profit | -137.95M | 123.49%23.46M | -75.96%-127.37M | -52.18%-99.86M | -72.39M | -234.70%-65.62M | -19.61M |
Financing income | --4.12M | -67.09%2.77M | -74.45%1.73M | -64.05%8.42M | --6.77M | 46.01%23.42M | --16.04M |
Financing cost | ---10.49M | -206.17%-12.8M | -585.68%-8.76M | -327.94%-4.18M | ---1.28M | 85.76%-977K | ---6.86M |
Share of profits of associates | ---202.7M | 17.37%-665.18M | 17.37%-470.73M | -17.13%-805.02M | ---569.68M | -109.24%-687.27M | ---328.46M |
Earning before tax | -347.01M | 27.63%-651.76M | 4.94%-605.13M | -23.30%-900.64M | -636.57M | -115.55%-730.45M | -338.88M |
Tax | ---2.94M | 84.85%-2.46M | 86.66%-1.59M | 0.96%-16.23M | ---11.9M | 45.14%-16.39M | ---29.87M |
After-tax profit from continuing operations | -349.96M | 28.65%-654.22M | 6.44%-606.72M | -22.77%-916.87M | -648.48M | -102.53%-746.84M | -368.75M |
Earning after tax | -349.96M | 28.65%-654.22M | 6.44%-606.72M | -22.77%-916.87M | -648.48M | -102.53%-746.84M | -368.75M |
Minority profit | --1.34M | 667.18%1.85M | 464.31%1.34M | -30.40%-326K | ---367K | 57.63%-250K | ---590K |
Profit attributable to shareholders | -351.29M | 28.42%-656.06M | 6.18%-608.06M | -22.76%-916.54M | -648.11M | -102.79%-746.59M | -368.16M |
Basic earnings per share | -0.34 | 27.78%-0.65 | 6.25%-0.6 | -21.62%-0.9 | -0.64 | -85.00%-0.74 | -0.4 |
Diluted earnings per share | -0.34 | 27.78%-0.65 | 6.25%-0.6 | -21.62%-0.9 | -0.64 | -85.00%-0.74 | -0.4 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data